India refrains from seeking East Jerusalem as capital of Palestine

DHNS
December 7, 2017

New Delhi, Dec 7: India on Thursday refrained from reiterating its long-held view that eastern part of the holy city of Jerusalem should be the capital of Palestine even as it declined to toe the US line to recognise the holy city s the capital of Israel.

"India's position on Palestine is independent and consistent. It is shaped by our views and interests and not determined by any third country," said Raveesh Kumar, spokesperson of the Ministry of External Affairs.

On Wednesday, US President Donald Trump formally recognised Jerusalem as the capital of Israel and set in motion a plan to shift the US Embassy from Tel Aviv to the holy city.
The US move evoked sharp criticism not only from the Arab world but also from Europe.

India's ambassador to Israel, like the envoys of all other nations, is based in Tel Aviv.

Though some nations maintain consulates in Jerusalem without recognising them as a diplomatic mission to either Israel or Palestine, New Delhi does not have any in the fiercely contested city.

Sources in New Delhi on Thursday indicated that India had no plan to shift its embassy to Jerusalem.

But New Delhi carefully avoided articulating its long-held position that Israel-Palestine conflict should be resolved through negotiation "resulting in sovereign, independent, viable and united State of Palestine, with East Jerusalem as its capital, living within secure and recognised borders, side by side at peace with Israel as endorsed in the Quartet Roadmap and relevant United Nations Security Council resolutions".

During his visit to Ramallah in October 2015, the then President Pranab Mukherjee had reiterated India's "principled support" to Palestinians' demand for East Jerusalem to be the capital of the State of Palestine.

New Delhi's long-held view was last articulated in India's statement presented at a committee of the United Nations General Assembly in New York on December 5, 2016.

India stopped calling for East Jerusalem to be the capital of Palestine this year.

Hosting Palestinian President Mahmoud Abbas in New Delhi in May, Prime Minister Narendra Modi did call for "a sovereign, independent, united and viable Palestine, co-existing peacefully with Israel", but avoided supporting the demand for East Jerusalem to be the capital of Palestine.

He carefully avoided referring to it during his visit to Israel in July, the first by a Prime Minister of India.

His message on the occasion of International Day of Solidarity with the Palestinian People on November 25 last or India's statement to UN General Assembly on November 29 last, too, did not refer to the call for East Jerusalem to be the capital of Palestine.

Modi's visit to Tel Aviv and Jerusalem in July substantially de-linked India's relations with Israel and Palestine.
Indian dignitaries visiting Israel in the past had made it a point to visit Palestine too.

Mukherjee had visited both Israel and Palestine. External Affairs Minister Sushma Swaraj, too, had visited Palestine after touring Israel in January 2016, just as one of her predecessors, S M Krishna, had done in October 2012.

India was the first non-Arab country to recognise Palestine way back in 1988.

But New Delhi's growing ties with Israel after the BJP's ascent to power in May 2014 fuelled speculation about India reviewing its position on Palestine.

The Narendra Modi government made it clear that while India would continue to support the cause of Palestine, it would also seek to build stronger ties with Israel.

New Delhi is now set to host Israel Prime Minister Benjamin Netanyahu who is likely to visit India next month.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 28,2020

New Delhi, Mar 28: The total number of coronavirus positive cases in the country has risen to 918 that include foreign nationals, the Ministry of Health and Family Welfare said on Saturday.

The ministry said: "The total positive cases of coronavirus are 918. The active COVID-19 cases are 819. Cured and discharged are 79. While 19 deaths have occurred so far. One person with COVID-19 migrated. As many as 15,24,266 passengers were screened at airports."

Prime Minister Narendra Modi on Tuesday announced a 21-day lockdown in the entire country to deal with the spread of coronavirus, saying that "social distancing" is the only option to deal with the disease, which spreads rapidly.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 3,2020

New Delhi, Jul 3: India reported the highest ever single-day spike of 20,903 COVID-19 cases in 24 hours on Friday, said the Union Ministry of Health and Family Welfare.

With these new cases, India's coronavirus tally has risen to 6,25,544 cases of which 2,27,439 patients are active cases while 3,79,892 patients have been cured/discharged/migrated.

379 more deaths due to COVID-19 were reported in the country in the last 24 hours, taking the number of deaths due to the infection to 18,213.

As per the Health Ministry, Maharashtra -- the worst-affected state from the virus -- has a total of 1,86,626 cases including 8,178 fatalities while Tamil Nadu has 98,392 coronavirus cases in the state inclusive of 1,321 fatalities.

Delhi has reported 92,175 cases so far inclusive of 2,864 patients succumbing to the virus.

The Indian Council of Medical Research on Friday said that the total number of samples tested till July 2 is 92,97,749 of which 2,41,576 samples were tested on Thursday.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 30,2020

Bengaluru, Apr 30: Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.

Favipiravir, manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

"After having successfully developed the API and the formulations ... Glenmark is all geared to immediately begin clinical trials on favipiravir on COVID-19 patients in India," Sushrut Kulkarni, executive vice-president for Global R&D, Glenmark Pharmaceuticals, said in a statement. 

The Drug Controller General of India, the country's drug regulator, did not immediately respond to Reuters request for comment.

On Wednesday, another Indian pharmaceutical company, Strides Pharma Science Ltd, said it had developed and commercialized favipiravir antiviral tablets, and had applied to Indian drug authorities to start trials.

Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%, as of 0407 GMT.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.